Title: SENATE BILL 331 By: Hines
Official Title: SENATE BILL 331 By: Hines
Number of Sections: 18
Source: versions - Introduced
Media Type: application/pdf
Strikethrough Detection: 7 sections found

================================================================================

Section 1:
1
STATE OF OKLAHOMA
1
2
1st Session of the 60th Legislature (2025)
2
3
3
4
4
5
5
6
AS INTRODUCED
6
7
An Act relating to schools; creating the Emerson Kate
7
Cole Act; providing short title; amending 70 O.S.
8
2021, Section 1-116.3, which relates to school
8
medication policies; updating statutory language;
9
updating statutory reference; requiring a school
9
employee to call 911 if Epinephrine is administered
10
to a student; requiring notification of a parent or
10
legal guardian if a student experiences a possible
11
allergic reaction; requiring annual training for
11
certain teachers and school employees; providing for
12
content and method of training; providing for
12
noncodification; providing an effective date; and
13
declaring an emergency.
13
14
14
15
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
15
16

Section 2:
SECTION 1. NEW LAW A new section of law not to be
16
17
codified in the Oklahoma Statutes reads as follows:
17
18
This act shall be known and may be cited as the “Emerson Kate
18
19
Cole Act”.
19
20

Section 3:
SECTION 2. AMENDATORY 70 O.S. 2021, Section 1-116.3, is
20
21
amended to read as follows:
21
22

Section 4:
Section 1-116.3. A. Notwithstanding the provisions of Section
22
23
1-116.2 of this title, the board of education of each school
23
24
district shall adopt a policy on or before September 1, 2008, that
24
Req. No. 661 Page 1
1
permits the self-administration of inhaled asthma medication by a
1
2
student for treatment of asthma, the self-administration of
2
3
anaphylaxis medication by a student for treatment of anaphylaxis,
3
4
and the self-administration of replacement pancreatic enzymes by a
4
5
student for treatment of cystic fibrosis. The policy shall require:
5
6

Section 5:
1. The parent or legal guardian of the student to authorize in
6
7
writing the student’s self-administration of medication;
7
8

Section 6:
2. The parent or legal guardian of the student to provide to
8
9
the school a written statement from the physician treating the
9
10
student that the student has asthma, anaphylaxis, or cystic fibrosis
10
11
and is capable of, and has been instructed in the proper method of,
11
12
self-administration of medication;
12
13

Section 7:
3. The parent or legal guardian of the student to provide to
13
14
the school an emergency supply of the student’s medication to be
14
15
administered pursuant to the provisions of Section 1-116.2 of this
15
16
title;
16
17

Section 8:
4. The school district to inform the parent or legal guardian
17
18
of the student, in writing, that the school district and its
18
19
employees and agents shall incur no liability as a result of any
19
20
injury arising from the self-administration of medication by the
20
21
student; and
21
22

Section 9:
5. The parent or legal guardian of the student to sign a
22
23
statement acknowledging that the school district shall incur no
23
24
24
Req. No. 661 Page 2
1
liability as a result of any injury arising from the self-
1
2
administration of medication by the student.
2
3
B. The school board of education of each school district that
3
4
elects to stock Epinephrine injectors or inhalers shall amend the
4
5
policy identified in subsection A of this section.
5
6

Section 10:
1. The amended policy for Epinephrine injectors shall require:
6
7
a. the school district to inform the parent or legal
7
8
guardian of each student, in writing, that a school
8
9
nurse or school employee trained by a health care
9
10
professional or trained in correlation with the State
10
11
Department of Health’s Diabetes Management Annual
11
12
School Training Program annual diabetes management
12
13
training may administer, with parent or legal guardian
13
14
permission but without a health care provider order,
14
15
an Epinephrine injection to a student whom the school
15
16
nurse or trained school employee in good faith
16
17
believes is having an anaphylactic reaction,
17
18
b. a waiver of liability executed by a parent or legal
18
19
guardian to be on file with the school district prior
19
20
to the administration of an Epinephrine injection
20
21
pursuant to subparagraph a of this paragraph 1 of this
21
22
subsection, and
22
23
23
24
24
Req. No. 661 Page 3
1
c. the school district to designate the employee
1
2
responsible for obtaining the Epinephrine injectors at
2
3
each school site.
3
4

Section 11:
2. The amended policy for inhalers shall require:
4
5
a. the school district to inform the parent or legal
5
6
guardian of each student, in writing, that a school
6
7
nurse or school employee trained by a health care
7
8
professional may administer an inhaler to a student
8
9
whom the school nurse or trained school employee in
9
10
good faith believes is having respiratory distress,
10
11
b. the school district to designate the employee
11
12
responsible for obtaining the inhalers and spacers or
12
13
holding chambers at each school site, and
13
14
c. the school district to notify the parent or legal
14
15
guardian of a student after administration of an
15
16
inhaler.
16
17
C. The school district and its employees and agents shall incur
17
18
no liability as a result of any injury arising pursuant to the
18
19
discharge or nondischarge of the powers provided for pursuant to
19
20
subparagraph a of paragraphs 1 and 2 of subsection B of this
20
21

Section 12:
section.
21
22
D. A licensed physician who has prescriptive authority may
22
23
write a prescription for Epinephrine injectors and inhalers and
23
24
spacers or holding chambers to the school district in the name of
24
Req. No. 661 Page 4
1
the district as a body corporate specified in Section 5-105 of this
1
2
title which shall be maintained at each school site. Such physician
2
3
shall incur no liability as a result of any injury arising from the
3
4
use of the Epinephrine injectors or the inhalers and spacers or
4
5
holding chambers.
5
6
E. The school district may maintain at each school a minimum of
6
7
two Epinephrine injectors and two inhalers with spacers or holding
7
8
chambers in a secure location. Provided, however, that nothing in
8
9
this section shall be construed as creating or imposing a duty on a
9
10
school district to maintain Epinephrine injectors or inhalers with
10
11
spacers or holding chambers at a school site or sites.
11
12
F. In the event a student is believed to be having an
12
13
anaphylactic reaction or respiratory distress, a school employee
13
14
shall contact 911 as soon as possible. If Epinephrine is
14
15
administered to a student, a school employee shall contact 911 as
15
16
soon as possible. The school district shall notify the parent or
16
17
legal guardian of any student who experiences a possible allergic
17
18
reaction as soon as possible.
18
19
G. The State Board of Education, in consultation with the State
19
20
Board of Health, shall develop model policies which school districts
20
21
may use in compliance with this section. The model policies shall
21
22
include, at a minimum, required annual training for teachers and
22
23
school employees who are directly responsible for students on the
23
24
topics of food allergies, recognizing anaphylaxis, and instruction
24
Req. No. 661 Page 5
1
on how to administer Epinephrine. The training shall be completed
1
2
before the school year begins or upon hiring the teacher or school
2
3
employee. Documentation certifying completion of the required
3
4
training shall be retained in the personnel file for the teacher or
4
5
school employee. The training may be provided online or in person
5
6
by the school nurse or a recognized food allergy and anaphylaxis
6
7
training program.
7
8
H. The State Board of Education, in consultation with the State
8
9
Board of Health, shall promulgate rules to implement this section.
9
10
I. As used in this section:
10
11

Section 13:
1. “Medication” means a metered dose inhaler or a dry powder
11
12
inhaler to alleviate asthmatic symptoms, prescribed by a physician
12
13
and having an individual label, an anaphylaxis medication used to
13
14
treat anaphylaxis including but not limited to Epinephrine injectors
14
15
prescribed by a physician and having an individual label, or
15
16
replacement pancreatic enzymes prescribed by a physician and having
16
17
an individual label; and
17
18

Section 14:
2. “Self-administration” means a student’s use of medication
18
19
pursuant to prescription or written direction from a physician.;
19
20

Section 15:
3. “Respiratory distress” means the perceived or actual
20
21
presence of coughing, wheezing, or shortness of breath; and
21
22

Section 16:
4. “Inhaler” means a device that delivers a bronchodilator to
22
23
alleviate symptoms of respiratory distress that is manufactured in
23
24
the form of a metered-dose inhaler or dry-powder inhaler and that
24
Req. No. 661 Page 6
1
may include a spacer or holding chamber that attaches to the inhaler
1
2
to improve the delivery of the bronchodilator.
2
3
J. The permission for self-administration of asthma,
3
4
anaphylaxis, or replacement pancreatic enzyme medication is
4
5
effective for the school year for which it is granted and shall be
5
6
renewed each subsequent school year upon fulfillment of the
6
7
requirements of this section.
7
8
K. A student who is permitted to self-administer asthma,
8
9
anaphylaxis, or replacement pancreatic enzyme medication pursuant to
9
10
this section shall be permitted to possess and use a prescribed
10
11
inhaler, anaphylaxis medication including but not limited to an
11
12
Epinephrine injector, or replacement pancreatic enzyme medication at
12
13
all times.
13
14

Section 17:
SECTION 3. This act shall become effective July 1, 2025.
14
15

Section 18:
SECTION 4. It being immediately necessary for the preservation
15
16
of the public peace, health, or safety, an emergency is hereby
16
17
declared to exist, by reason whereof this act shall take effect and
17
18
be in full force from and after its passage and approval.
18
19
19
20
60-1-661 EB 1/2/2025 7:52:18 AM
20
21
21
22
22
23
23
24
24
Req. No. 661 Page 7
[DELETED:  P B H]
[DELETED:  P]
[DELETED:  P t a]
[DELETED:  P t t t t]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P E 1]


================================================================================

Raw Text:
1
STATE OF OKLAHOMA
1
2
1st Session of the 60th Legislature (2025)
2
3
SENATE BILL 331 By: Hines
3
4
4
5
5
6
AS INTRODUCED
6
7
An Act relating to schools; creating the Emerson Kate
7
Cole Act; providing short title; amending 70 O.S.
8
2021, Section 1-116.3, which relates to school
8
medication policies; updating statutory language;
9
updating statutory reference; requiring a school
9
employee to call 911 if Epinephrine is administered
10
to a student; requiring notification of a parent or
10
legal guardian if a student experiences a possible
11
allergic reaction; requiring annual training for
11
certain teachers and school employees; providing for
12
content and method of training; providing for
12
noncodification; providing an effective date; and
13
declaring an emergency.
13
14
14
15
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
15
16
SECTION 1. NEW LAW A new section of law not to be
16
17
codified in the Oklahoma Statutes reads as follows:
17
18
This act shall be known and may be cited as the “Emerson Kate
18
19
Cole Act”.
19
20
SECTION 2. AMENDATORY 70 O.S. 2021, Section 1-116.3, is
20
21
amended to read as follows:
21
22
Section 1-116.3. A. Notwithstanding the provisions of Section
22
23
1-116.2 of this title, the board of education of each school
23
24
district shall adopt a policy on or before September 1, 2008, that
24
Req. No. 661 Page 1

1
permits the self-administration of inhaled asthma medication by a
1
2
student for treatment of asthma, the self-administration of
2
3
anaphylaxis medication by a student for treatment of anaphylaxis,
3
4
and the self-administration of replacement pancreatic enzymes by a
4
5
student for treatment of cystic fibrosis. The policy shall require:
5
6
1. The parent or legal guardian of the student to authorize in
6
7
writing the student’s self-administration of medication;
7
8
2. The parent or legal guardian of the student to provide to
8
9
the school a written statement from the physician treating the
9
10
student that the student has asthma, anaphylaxis, or cystic fibrosis
10
11
and is capable of, and has been instructed in the proper method of,
11
12
self-administration of medication;
12
13
3. The parent or legal guardian of the student to provide to
13
14
the school an emergency supply of the student’s medication to be
14
15
administered pursuant to the provisions of Section 1-116.2 of this
15
16
title;
16
17
4. The school district to inform the parent or legal guardian
17
18
of the student, in writing, that the school district and its
18
19
employees and agents shall incur no liability as a result of any
19
20
injury arising from the self-administration of medication by the
20
21
student; and
21
22
5. The parent or legal guardian of the student to sign a
22
23
statement acknowledging that the school district shall incur no
23
24
24
Req. No. 661 Page 2

1
liability as a result of any injury arising from the self-
1
2
administration of medication by the student.
2
3
B. The school board of education of each school district that
3
4
elects to stock Epinephrine injectors or inhalers shall amend the
4
5
policy identified in subsection A of this section.
5
6
1. The amended policy for Epinephrine injectors shall require:
6
7
a. the school district to inform the parent or legal
7
8
guardian of each student, in writing, that a school
8
9
nurse or school employee trained by a health care
9
10
professional or trained in correlation with the State
10
11
Department of Health’s Diabetes Management Annual
11
12
School Training Program annual diabetes management
12
13
training may administer, with parent or legal guardian
13
14
permission but without a health care provider order,
14
15
an Epinephrine injection to a student whom the school
15
16
nurse or trained school employee in good faith
16
17
believes is having an anaphylactic reaction,
17
18
b. a waiver of liability executed by a parent or legal
18
19
guardian to be on file with the school district prior
19
20
to the administration of an Epinephrine injection
20
21
pursuant to subparagraph a of this paragraph 1 of this
21
22
subsection, and
22
23
23
24
24
Req. No. 661 Page 3

1
c. the school district to designate the employee
1
2
responsible for obtaining the Epinephrine injectors at
2
3
each school site.
3
4
2. The amended policy for inhalers shall require:
4
5
a. the school district to inform the parent or legal
5
6
guardian of each student, in writing, that a school
6
7
nurse or school employee trained by a health care
7
8
professional may administer an inhaler to a student
8
9
whom the school nurse or trained school employee in
9
10
good faith believes is having respiratory distress,
10
11
b. the school district to designate the employee
11
12
responsible for obtaining the inhalers and spacers or
12
13
holding chambers at each school site, and
13
14
c. the school district to notify the parent or legal
14
15
guardian of a student after administration of an
15
16
inhaler.
16
17
C. The school district and its employees and agents shall incur
17
18
no liability as a result of any injury arising pursuant to the
18
19
discharge or nondischarge of the powers provided for pursuant to
19
20
subparagraph a of paragraphs 1 and 2 of subsection B of this
20
21
section.
21
22
D. A licensed physician who has prescriptive authority may
22
23
write a prescription for Epinephrine injectors and inhalers and
23
24
spacers or holding chambers to the school district in the name of
24
Req. No. 661 Page 4

1
the district as a body corporate specified in Section 5-105 of this
1
2
title which shall be maintained at each school site. Such physician
2
3
shall incur no liability as a result of any injury arising from the
3
4
use of the Epinephrine injectors or the inhalers and spacers or
4
5
holding chambers.
5
6
E. The school district may maintain at each school a minimum of
6
7
two Epinephrine injectors and two inhalers with spacers or holding
7
8
chambers in a secure location. Provided, however, that nothing in
8
9
this section shall be construed as creating or imposing a duty on a
9
10
school district to maintain Epinephrine injectors or inhalers with
10
11
spacers or holding chambers at a school site or sites.
11
12
F. In the event a student is believed to be having an
12
13
anaphylactic reaction or respiratory distress, a school employee
13
14
shall contact 911 as soon as possible. If Epinephrine is
14
15
administered to a student, a school employee shall contact 911 as
15
16
soon as possible. The school district shall notify the parent or
16
17
legal guardian of any student who experiences a possible allergic
17
18
reaction as soon as possible.
18
19
G. The State Board of Education, in consultation with the State
19
20
Board of Health, shall develop model policies which school districts
20
21
may use in compliance with this section. The model policies shall
21
22
include, at a minimum, required annual training for teachers and
22
23
school employees who are directly responsible for students on the
23
24
topics of food allergies, recognizing anaphylaxis, and instruction
24
Req. No. 661 Page 5

1
on how to administer Epinephrine. The training shall be completed
1
2
before the school year begins or upon hiring the teacher or school
2
3
employee. Documentation certifying completion of the required
3
4
training shall be retained in the personnel file for the teacher or
4
5
school employee. The training may be provided online or in person
5
6
by the school nurse or a recognized food allergy and anaphylaxis
6
7
training program.
7
8
H. The State Board of Education, in consultation with the State
8
9
Board of Health, shall promulgate rules to implement this section.
9
10
I. As used in this section:
10
11
1. “Medication” means a metered dose inhaler or a dry powder
11
12
inhaler to alleviate asthmatic symptoms, prescribed by a physician
12
13
and having an individual label, an anaphylaxis medication used to
13
14
treat anaphylaxis including but not limited to Epinephrine injectors
14
15
prescribed by a physician and having an individual label, or
15
16
replacement pancreatic enzymes prescribed by a physician and having
16
17
an individual label; and
17
18
2. “Self-administration” means a student’s use of medication
18
19
pursuant to prescription or written direction from a physician.;
19
20
3. “Respiratory distress” means the perceived or actual
20
21
presence of coughing, wheezing, or shortness of breath; and
21
22
4. “Inhaler” means a device that delivers a bronchodilator to
22
23
alleviate symptoms of respiratory distress that is manufactured in
23
24
the form of a metered-dose inhaler or dry-powder inhaler and that
24
Req. No. 661 Page 6

1
may include a spacer or holding chamber that attaches to the inhaler
1
2
to improve the delivery of the bronchodilator.
2
3
J. The permission for self-administration of asthma,
3
4
anaphylaxis, or replacement pancreatic enzyme medication is
4
5
effective for the school year for which it is granted and shall be
5
6
renewed each subsequent school year upon fulfillment of the
6
7
requirements of this section.
7
8
K. A student who is permitted to self-administer asthma,
8
9
anaphylaxis, or replacement pancreatic enzyme medication pursuant to
9
10
this section shall be permitted to possess and use a prescribed
10
11
inhaler, anaphylaxis medication including but not limited to an
11
12
Epinephrine injector, or replacement pancreatic enzyme medication at
12
13
all times.
13
14
SECTION 3. This act shall become effective July 1, 2025.
14
15
SECTION 4. It being immediately necessary for the preservation
15
16
of the public peace, health, or safety, an emergency is hereby
16
17
declared to exist, by reason whereof this act shall take effect and
17
18
be in full force from and after its passage and approval.
18
19
19
20
60-1-661 EB 1/2/2025 7:52:18 AM
20
21
21
22
22
23
23
24
24
Req. No. 661 Page 7

[DELETED:  P B H]
[DELETED:  P]
[DELETED:  P t a]
[DELETED:  P t t t t]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P E 1]